BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 4734062)

  • 1. Primary polycythaemia. 3. Studies on the significance of the history of the disease and of the treatment for the development of clones in bone marrow cells.
    Visfeldt J; Franzén S; Nielsen A; Tribukait B
    Acta Pathol Microbiol Scand A; 1973 Mar; 81(2):195-203. PubMed ID: 4734062
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow biopsy in polycythaemia vera.
    Krasznai G; Nagy G; Rácz M
    Acta Med Acad Sci Hung; 1969; 26(4):309-16. PubMed ID: 5380803
    [No Abstract]   [Full Text] [Related]  

  • 3. Patho-anatomical features of the bone marrow.
    Lennert K; Nagai K; Schwarze EW
    Clin Haematol; 1975 Jun; 4(2):331-51. PubMed ID: 1102191
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bone marrow histology and clinical aspects of polycythemia vera].
    Burkhardt R; Pabst W; Kleber A
    Arch Klin Med; 1969; 216(1):64-104. PubMed ID: 4889911
    [No Abstract]   [Full Text] [Related]  

  • 5. Management and therapy of polycythaemia vera.
    Israëls MC
    Br J Haematol; 1969 Sep; 17(3):305. PubMed ID: 5257763
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy in polycythemia vera.
    Stecher G; Reinhardt G
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):292-302. PubMed ID: 5241850
    [No Abstract]   [Full Text] [Related]  

  • 7. Pipobroman (Vercyte) - a new antineoplastic drug.
    Med Lett Drugs Ther; 1967 Apr; 9(7):27. PubMed ID: 5298493
    [No Abstract]   [Full Text] [Related]  

  • 8. [Histologic bone marrow findings in polycythemia vera before and after P32 therapy. (At the same time a contribution to the differential diagnosis of the clinical feature "polycythemia")].
    Hauswaldt C; Hunstein W; Uhl N; Doering P
    Arch Klin Med; 1967; 213(3):219-36. PubMed ID: 5594424
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the phagocytic activity of neutrophilic leukocytes.
    Brandt L
    Scand J Haematol Suppl; 1967; 2():1-126. PubMed ID: 5243720
    [No Abstract]   [Full Text] [Related]  

  • 10. [Polycythemia vera: therapeutic use of busulfan. Comparison with radioactive phosphorous].
    Jamra M; Verrastro T
    Rev Hosp Clin Fac Med Sao Paulo; 1967; 22():Suppl:241-66. PubMed ID: 5629089
    [No Abstract]   [Full Text] [Related]  

  • 11. [Onset of polycythemia in idiopathic myelofibrosis. Description of a clinical case and review of the literature].
    Pagano L; Teofili L; Marra R; Storti S; Rabbitti C; Leone G; Bizzi B
    Minerva Med; 1988 Jan; 79(1):51-4. PubMed ID: 3277085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycythaemia vera and myelofibrosis.
    Ikkala E; Rapola J; Kotilainen M
    Scand J Haematol; 1967 Dec; 4(6):453-64. PubMed ID: 6082224
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute leukemia in polycythemia vera.
    Landaw SA
    Semin Hematol; 1986 Apr; 23(2):156-65. PubMed ID: 3704667
    [No Abstract]   [Full Text] [Related]  

  • 14. The management of polycythaemia vera.
    Wasserman LR
    Br J Haematol; 1971 Oct; 21(4):371-6. PubMed ID: 4941523
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of polycythaemia vera.
    Br Med J; 1966 Jul; 2(5507):186-7. PubMed ID: 5939091
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of polycythemia vera with busulfan (myleran). Report on results in 40 patients].
    Urasiński I; Mysik M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(4):360-6. PubMed ID: 4101127
    [No Abstract]   [Full Text] [Related]  

  • 17. [Development of polycythemia vera during chronic idiopathic myelofibrosis].
    Paladini G; Tosato F; Mazzanti G; Covaz E
    Minerva Med; 1985 Dec; 76(49-50):2315-7. PubMed ID: 4088526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of Polycythemia vera and thrombocythemia with myleran (busulphan).
    Epstein IS
    Isr J Med Sci; 1965 Jul; 1(4):797-9. PubMed ID: 5892718
    [No Abstract]   [Full Text] [Related]  

  • 19. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome.
    Ward HP; Block MH
    Medicine (Baltimore); 1971 Sep; 50(5):357-420. PubMed ID: 4940717
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical course and transformation of polycythemia vera and its relation to applied therapy].
    Burger T; Schmelczer M; Molnár L; Pajor L; Koszorús S
    Orv Hetil; 1987 Dec; 128(52):2723-30. PubMed ID: 3431872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.